Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Hokuriku Seiyaku claims new thiourea antibacterial agents

May 25, 1999

Trial results presented at ACOG meeting support efficacy and safety of imiquimod 5% cream

May 21, 1999

Abbott reports preparation and activity of novel erythromycin ketolides

May 21, 1999

Tremacamra reduces cold symptoms, opens new avenues in rhinovirus research

May 19, 1999

Merck's new carbapenems useful against methicillin-resistant staphylococci

May 18, 1999

Xoma concludes patient enrollment in Neuprex phase III pivotal trial

May 18, 1999

Antirotavirus polymers in development at GelTex

May 17, 1999

RD3-0028 is effective in treating RSV infection in mice

May 14, 1999

Periodontix announces phase I/II trial of histatin-based mouthwash for oral candidiasis

May 14, 1999

P&G presents new antimicrobial agents with broad spectrum, including resistant bacteria

May 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....